Harmony BiosciencesHRMY
About: Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
Employees: 246
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
119% more call options, than puts
Call options by funds: $4.39M | Put options by funds: $2M
44% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 27
29% more capital invested
Capital invested by funds: $1.54B [Q2] → $1.99B (+$449M) [Q3]
20% more funds holding in top 10
Funds holding in top 10: 5 [Q2] → 6 (+1) [Q3]
6% more funds holding
Funds holding: 218 [Q2] → 230 (+12) [Q3]
2.34% less ownership
Funds ownership: 89.81% [Q2] → 87.48% (-2.34%) [Q3]
20% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 86
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
HC Wainwright & Co. Patrick Trucchio 30% 1-year accuracy 47 / 158 met price target | 120%upside $75 | Buy Initiated | 17 Dec 2024 |
Cantor Fitzgerald Charles Duncan 39% 1-year accuracy 32 / 82 met price target | 70%upside $58 | Overweight Maintained | 30 Oct 2024 |
Oppenheimer Francois Brisebois 43% 1-year accuracy 15 / 35 met price target | 73%upside $59 | Outperform Reiterated | 30 Oct 2024 |
Needham Ami Fadia 32% 1-year accuracy 49 / 154 met price target | 53%upside $52 | Buy Reiterated | 30 Oct 2024 |
Raymond James Danielle Brill 50% 1-year accuracy 7 / 14 met price target | 17%upside $40 | Outperform Reinstated | 10 Oct 2024 |
Financial journalist opinion
Based on 19 articles about HRMY published over the past 30 days